Clinical Trials Browser

Phase 2/3 × Has results × Pemetrexed × Clear all

NCT02784171 2024-12-10

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Phase 2/3 Completed

520 enrolled 16 charts 1 FDA

Other solid neoplasmThoracic

Mesothelioma

NCT02709512 2023-10-04

ATOMIC

Phase 2/3 Completed

249 enrolled 17 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT01907100 2019-03-18

Nintedanib (BIBF 1120) in Mesothelioma

Phase 2/3 Terminated

545 enrolled 15 charts

Other solid neoplasmThoracic

Mesothelioma